TP53 and cancer: Mutations that alter these specific arginine residues in p53 have been detected in human cancers and the R337H mutation is associated with cancer risk in a Brazilian family [8], highlighting the potential importance of arginine methylation in the control of p53-mediated events and oncogenesis.